UNSPSC 51171720: Alosetron hydrochloride

This classification denotes a 5-ht3 receptor antagonist with the molecular formula C17H18N4O.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2F5R1A46YW, chemically known as 2,3,4,5-tetrahydro-5-methyl-2-((5-methylimidazol-4-yl)methyl)-1h-pyrido(4,3-b)indol-1-one monohydrochloride but more generally known as alosetron hydrochloride, which bears US NIH Compound Identifier 60758. The base compound, Alosetron, comes in base and hydrochloride forms.

UNSPSC 51171720 Alosetron hydrochloride is a Commodity code that classifies pharmaceutical products, yet recent state and local procurement activity under this code does not reflect purchases of the named drug itself. Instead, Collin County Community Supervision and Corrections Department issued RFP 2026-327 in September 2026 for offender specimen collection and drug testing services—a scope entirely unrelated to alosetron hydrochloride procurement. The mismatch suggests either a coding error in the source data or that this Commodity code carries little relevant recent activity in state and local government purchasing. The specimen-collection opportunity encompasses staffing two collection sites in Plano and McKinney, operating an Interactive Voice Response system for randomized testing notifications, immunoassay screening with LC/MS/MS or GC/MS confirmation, electronic result reporting, and alternative testing methodologies including oral fluid and hair testing, with an estimated contract value of $600,000 over an initial two-year term (September 1, 2026 through August 31, 2028) plus three optional one-year renewals.

The single recent opportunity identified originated from Collin County, Texas, a county-level criminal justice agency rather than a state department or municipal government. The RFP response deadline was July 23, 2026 at 2:00 p.m., with an anticipated award date of August 10, 2026. Annual testing demand is approximately 25,031 tests across five-panel screens, six-panel screens, and ancillary testing. The successful vendor must maintain lab certification from SAMHSA, Texas Department of Public Safety, or CAP, with pricing submitted on a per-test basis across three service models: screening only, confirmation after screening, and screening with automatic confirmation of positives. Evaluation criteria include vendor understanding (30 points), firm qualifications (25 points), client references (15 points), cost (30 points), and optional Phase 2 demonstrations and interviews (up to 30 points). The lack of additional recent opportunities under this code suggests limited current procurement activity aligned with alosetron hydrochloride as a pharmaceutical input to state and local government operations.